Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Nov 7, 2016 · 10-Q · 38 days after period end · 0001564590-16-027730
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$67.00K | -$125.00K | -$291.00K | $900.00K |
| EPS Diluted | -$0.07 | $0.00 | -$0.01 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 7, 2016 · 38 d after period end
